PETMED EXPRESS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.02 USD | -0.74% |
|
-2.19% | -46.83% |
| Apr. 15 | Earnings Flash (PETS) PETMED EXPRESS Posts Q3 Revenue $65.3M | MT |
| Apr. 15 | PetMed Express, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 466.6 | 575.1 | 706.8 | 521.9 | 330.1 | 81.99 | - | - |
| Enterprise Value (EV) 1 | 366.1 | 471.4 | 588.1 | 410.9 | 226 | 34.33 | 35.46 | 35.61 |
| P/E ratio | 12.4 x | 22.3 x | 23.1 x | 24.8 x | 1,624 x | -21.2 x | -402 x | 30.9 x |
| Yield | 4.65% | 3.75% | 3.18% | 4.65% | 7.39% | 14.9% | 14.9% | 14.9% |
| Capitalization / Revenue | 1.65 x | 2.02 x | 2.29 x | 1.91 x | 1.29 x | 0.29 x | 0.27 x | 0.25 x |
| EV / Revenue | 1.29 x | 1.66 x | 1.9 x | 1.5 x | 0.88 x | 0.12 x | 0.12 x | 0.11 x |
| EV / EBITDA | 7.56 x | 14.2 x | 14.7 x | 14.4 x | 11.4 x | 3.43 x | 3.02 x | - |
| EV / FCF | 8,223,010 x | 12,902,300 x | 15,622,898 x | 24,534,268 x | 10,025,382 x | - | - | - |
| FCF Yield | 0% | 0% | 0% | 0% | 0% | - | - | - |
| Price to Book | 3.47 x | 4.44 x | 5.01 x | 3.69 x | 2.77 x | 0.71 x | 0.73 x | 0.75 x |
| Nbr of stocks (in thousands) | 20,483 | 19,983 | 20,094 | 20,230 | 20,325 | 20,396 | - | - |
| Reference price 2 | 22.78 | 28.78 | 35.18 | 25.80 | 16.24 | 4.020 | 4.020 | 4.020 |
| Announcement Date | 5/6/19 | 5/4/20 | 5/3/21 | 5/9/22 | 5/22/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 283.4 | 284.1 | 309.2 | 273.4 | 256.9 | 279.6 | 299.7 | 324.9 |
| EBITDA 1 | 48.4 | 33.23 | 40.01 | 28.45 | 19.77 | 9.999 | 11.76 | - |
| EBIT 1 | 46.17 | 30.98 | 37.59 | 26.43 | -1.43 | -6.604 | -2.954 | -0.41 |
| Operating Margin | 16.29% | 10.9% | 12.16% | 9.67% | -0.56% | -2.36% | -0.99% | -0.13% |
| Earnings before Tax (EBT) 1 | 49.12 | 33.89 | 39.22 | 27.07 | 1.584 | -4.641 | -0.0478 | 3.686 |
| Net income 1 | 37.74 | 25.85 | 30.6 | 21.1 | 0.233 | -3.927 | -0.1192 | 2.746 |
| Net margin | 13.32% | 9.1% | 9.9% | 7.72% | 0.09% | -1.4% | -0.04% | 0.85% |
| EPS 2 | 1.840 | 1.290 | 1.520 | 1.040 | 0.0100 | -0.1900 | -0.0100 | 0.1300 |
| Free Cash Flow | 44.52 | 36.53 | 37.64 | 16.75 | 22.54 | - | - | - |
| FCF margin | 15.71% | 12.86% | 12.17% | 6.12% | 8.78% | - | - | - |
| FCF Conversion (EBITDA) | 91.98% | 109.93% | 94.07% | 58.87% | 114.03% | - | - | - |
| FCF Conversion (Net income) | 117.96% | 141.32% | 123% | 79.36% | 9,675.11% | - | - | - |
| Dividend per Share 2 | 1.060 | 1.080 | 1.120 | 1.200 | 1.200 | 0.6000 | 0.6000 | 0.6000 |
| Announcement Date | 5/6/19 | 5/4/20 | 5/3/21 | 5/9/22 | 5/22/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 67.39 | 60.72 | 66 | 70.19 | 65.39 | 58.87 | 62.41 | 78.24 | 71 | 65.32 | 65 | 79.42 | 72.06 | 66.3 | 65.98 |
| EBITDA 1 | 8.781 | 7.584 | 7.744 | 6.332 | 7.05 | 2.74 | 3.648 | 3.335 | 3.17 | 0.924 | 1.673 | 3.191 | 3.081 | 2.494 | 2.99 |
| EBIT 1 | 8.087 | 5.147 | 7.057 | 3.49 | 2.961 | -0.769 | -7.112 | -2.128 | -0.441 | -3.074 | -2.277 | -1.191 | -1.081 | -1.494 | -0.99 |
| Operating Margin | 12% | 8.48% | 10.69% | 4.97% | 4.53% | -1.31% | -11.4% | -2.72% | -0.62% | -4.71% | -3.5% | -1.5% | -1.5% | -2.25% | -1.5% |
| Earnings before Tax (EBT) 1 | 8.331 | 5.518 | 7.434 | 3.805 | 3.61 | 0.198 | -6.029 | -1.002 | 0.383 | -2.645 | -1.848 | -0.762 | -0.652 | -1.065 | -0.561 |
| Net income 1 | 6.349 | 4.257 | 6.066 | 2.775 | 2.579 | -0.019 | -5.102 | -0.887 | -0.07 | -2.027 | -1.479 | -0.61 | -0.522 | -0.852 | -0.449 |
| Net margin | 9.42% | 7.01% | 9.19% | 3.95% | 3.94% | -0.03% | -8.18% | -1.13% | -0.1% | -3.1% | -2.28% | -0.77% | -0.72% | -1.29% | -0.68% |
| EPS 2 | 0.3100 | 0.2100 | 0.3000 | 0.1400 | 0.1300 | - | -0.2500 | -0.0400 | - | -0.1000 | -0.0700 | -0.0100 | 0.0100 | -0.0100 | 0.005000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/25/21 | 1/24/22 | 5/9/22 | 7/25/22 | 11/7/22 | 2/6/23 | 5/22/23 | 7/31/23 | 10/30/23 | 4/15/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 101 | 104 | 119 | 111 | 104 | 47.7 | 46.5 | 46.4 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | 44.5 | 36.5 | 37.6 | 16.7 | 22.5 | - | - | - |
| ROE (net income / shareholders' equity) | 30.1% | 19.5% | 22.6% | 14.9% | 2.02% | 0.1% | 1.88% | 2.41% |
| ROA (Net income/ Total Assets) | 26.1% | 16.7% | 17.9% | 11.6% | 1.58% | - | - | - |
| Assets 1 | 144.6 | 154.9 | 171.4 | 181.9 | 14.74 | - | - | - |
| Book Value Per Share 2 | 6.570 | 6.480 | 7.020 | 6.980 | 5.870 | 5.660 | 5.500 | 5.360 |
| Cash Flow per Share | 2.200 | 1.940 | 1.990 | 0.9100 | 1.370 | - | - | - |
| Capex | 0.62 | 2.31 | 2.43 | 1.75 | 5.26 | - | - | - |
| Capex / Sales | 0.22% | 0.81% | 0.79% | 0.64% | 2.05% | - | - | - |
| Announcement Date | 5/6/19 | 5/4/20 | 5/3/21 | 5/9/22 | 5/22/23 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4.02
USD
Average target price
7.75
USD
Spread / Average Target
+92.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -46.83% | 81.99M | |
| -12.86% | 8.57B | |
| +32.95% | 1.32B | |
| +6.76% | 419M | |
| +5.93% | 282M | |
| +10.56% | 224M | |
| -8.26% | 85.07M | |
| +20.94% | 59.57M |
- Stock Market
- Equities
- PETS Stock
- Financials PetMed Express, Inc.
